Olmesartan Medoxomil/ Rosuvastatin 20/10 mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Korea Prime Pharm Co., Ltd.
MFDS item code 202003983 · Approved 2020.05.28
This product's status changed to Approval withdrawn on 2024.09.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
(Treatment of hypertension, hypercholesterolemia) and reduction of cardiovascular disease risk
This medication is prescribed for patients who need to take both ingredients, olmesartan medoxomil and rosuvastatin. Olmesartan medoxomil is primarily used to treat essential hypertension. Rosuvastatin helps with primary hypercholesterolemia and mixed hyperlipidemia that are not controlled by diet and exercise, and it is also used as an adjunctive treatment for familial homozygous hypercholesterolemia and primary dysbetalipoproteinemia. Additionally, it lowers cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis and effectively reducing the risk of stroke, myocardial infarction, and revascularization procedures in patients at high risk of cardiovascular diseases. The combination of these two medications simultaneously improves blood pressure and blood lipid management, effectively protecting the cardiovascular health of patients.
Olmesartan Medoxomil: The recommended initial dose for adults is 10mg once daily, taken without regard to meals. If blood pressure is not adequately controlled, the dose may be increased to 20mg once daily, with a maximum of up to 40mg. The antihypertensive effect appears within 2 weeks of starting treatment, with the maximum effect observed at around 8 weeks. If necessary, thiazide diuretics can be co-administered. It is advisable to take it at the same time every day.
Safety and effectiveness in children under 18 years of age have not been established, so it should not be administered.
This medication can cause serious harm to the fetus and neonate if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication or its components, pregnant or potentially pregnant women, and lactating women should not take it. Patients with significantly impaired renal function, those undergoing kidney dialysis, severe liver dysfunction, or biliary obstruction should not use this medication. Patients with a history of muscle disorders or those at high risk of muscle problems must consult their doctor before taking this medication, and should avoid high-dose administration. This medication contains lactose, so patients with certain genetic lactose intolerance should not take it. Patients with low blood pressure or low salt levels may experience hypotensive symptoms at the beginning of treatment, so they should be monitored closely. Patients with weakened renal function or those who have had a kidney transplant should have their renal function and electrolyte levels monitored regularly through blood tests. Due to the risk of hyperkalemia, potassium levels should be checked periodically, and patients with heart or blood pressure-related conditions require special attention. This medication may cause muscle pain, muscle weakness, and rarely severe muscle damage known as rhabdomyolysis; if symptoms of muscle pain or weakness occur, notify medical personnel immediately. Liver function abnormalities may occur, so liver function tests should be performed regularly before and during treatment with this medication. Dizziness or drowsiness may occur, so caution is needed when driving or operating hazardous machinery. This medication may interact with other drugs, so inform your doctor or pharmacist if you are taking other medications. Pregnant or nursing women should not take this medication, and women who may become pregnant should use appropriate contraceptive methods. Safety for use in children or adolescents under 18 has not been established. Elderly patients may have higher blood concentrations of this medication, so dose adjustment and caution are necessary. In case of overdose, hypotension or cardiac irregularities may occur, requiring immediate medical attention and appropriate treatment if necessary. This medication should be kept out of reach of children and should not be transferred to another container.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rashes with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, difficulty breathing or wheezing, asthma attacks, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, mental confusion, visual disturbances, paralysis, urinary symptoms, etc.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture, and the storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This will safely maintain the medication's efficacy.
White or pale yellow round film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Korea Prime Pharm Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.